Intravenous immunoglobulin (IVIG) treatment for modulation of immune activation in human immunodeficiency virus type 1 infected therapy-naive individuals

Immunology and Microbiology

• T-Helper Cell 100%
• T Cell Activation 60%
• Human Immunodeficiency Virus 50%
• CD4 Lymphocyte Count 40%
• Intravenous Immunoglobulin 40%
• Cytotoxic T-Cell 40%
• CD4 20%
• Immunity 20%
• HLA-DR 10%
• Modulation 10%
• Blood Level 10%
• Human Immunodeficiency Virus 1 10%
• Blood Plasma 10%
• Cell Count 10%
• Cell Loss 10%
• CD38 10%
• Cells 10%
• Aptitude 10%

Medicine and Dentistry

• Immunoglobulin 40%
• Cell Count 40%
• Human Immunodeficiency Virus 1 Infection 30%
• Human Immunodeficiency Virus 20%
• Infusion 20%
• Combination Therapy 20%
• Plasma 20%
• RNA 10%
• Follow up 10%
• Antiretroviral Therapy 10%
• Human Immunodeficiency Virus 1 10%
• Hyperactivation 10%
• Cell Loss 10%
• Cells 10%
• Therapeutic Procedure 10%
• Aptitude 10%
• T Cell 10%
• Patient 10%